Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis

Blood

Volumn 94, Issue 1, 1999, Pages 208-215

  Bacsi, S ^b   De Palma, R ^b   Visentin, G P ^b   Gorski, J ^b   Aster, R H ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; T LYMPHOCYTE RECEPTOR; THROMBOCYTE FACTOR; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTERY THROMBOSIS; ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HELPER CELL; HUMAN; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0033168323     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.208.413a06_208_215     Document Type: Article

References (39)

1. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95, 1992 (letter)
2. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81, 1994
3. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, DeNomme GA, Horsewood P: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232, 1994
4. Greinacher A, Potzsch B, Admiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multi-molecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247, 1994
5. Aster RH: Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332:1374, 1995
6. Visentin GP, Malik M, Cyganiak KA, Aster RH: Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Med 128:376, 1996
7. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD: Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95:1242, 1997
8. Suh JS, Malik MI, Aster RH, Visentin GP: Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol 54:196, 1997
9. Maslanka K, Piatek T, Gorski J, Yassai M: Molecular analysis of T cell repertoires. Spectrotypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol 44:28, 1995
10. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27, 1986
11. Gorski J, Yassai M, Zhu X, Kissella B, Keever C, Flomenberg N: Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectrotyping. Correlation with immune status. J Immunol 152:5109, 1994
12. Rock EP, Sibbald PR, Davis MM, Chien YH: CDR3 length in antigen-specific immune receptors. J Exp Med 179:323, 1994
13. Warkentin TE, Chong BH, Greinacher A: Heparin-induced thrombocytopenia: Toward consensus. Thromb Haemost 79:1, 1998
14. Suh JS, Aster RH, Visentin GP: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin:platelet factor 4. Blood 91:1, 1998
15. Visentin GP, Moghaddam M, Collins JL, McFarland JG, Aster RH: Antibodies associated with heparin-induced thrombocytopenia (HIT) report confirmational changes in platelet factor 4 (PF4) induced by linear, polyanionic compounds. Blood 90:460a, 1997 (suppl 1, abstr)
16. Chong BH, Newman PM: The antigenic epitope in heparin-induced thrombocytopenia resides solely on platelet factor 4. Blood 90:461a, 1997 (suppl 1, abstr)
17. Amiral J, Bridey F, Wolf M, Boyer-Newmann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Drefus M, Meyer D: Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 73:21, 1995
18. DePalma R, Gorski J: Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci USA 92:8836, 1995
19. Naumov Y, Hogan K, Naumova E, Pagel J, Gorski J: A class I MHC restricted recall response to a viral peptide is highly polyclonal despite a stringent CDR3 selection: Implications for establishing memory T cell repertoires in "real-world" conditions. J Immunol 160:2842, 1998
20. Maslanka K, Yassai M, Gorski J: Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 98:1802, 1996
21. Hedrick SM, Engel I, McElligot DL, Fink PJ, Hsu ML, Hansburg D, Matis LA: Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science 239:1541, 1988
22. Fink PJ, Matis LA, McElligot DL, Bookman M, Hedrick SM: Correlations between T cell specificity and the structure of the antigen receptor. Nature 321:219, 1986
23. Winoto A, Urban JL, Lan NC, Goverman J, Hood L, Hansburg D: Predominant use of a V alpha gene segment in mouse T cell receptors for cytochrome c. Nature 324:679, 1986
24. Acha-Orbea H, Mitchell DJ, Timmerman L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L: Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263, 1988
25. Urban JL, Kumar V, Kondo DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577, 1988
26. Lai MZ, Yang YJ, Chen LK, Gefter ML: Restricted V-(D)-J junctional regions in the T cell response to lambda repressor: Identification of residues critical for antigen recognition. J Immunol 144:4851, 1990
27. Danska JS, Livingstone AM, Paragas V, Ishihara T, Fathman CG: The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine the T cell specificity for myoglobin peptides. J Exp Med 172:27, 1990
28. Jorgensen JL, Esser U, de St. Groth BF, Reay PA, Davis MM: Mapping T cell receptor-peptide contacts by variant peptide immunization of single chain transgenics. Nature 355:224, 1992
29. Pierce JL, Zborowski KA, Kraig E, Infante AJ: Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Int Immunol 6:775, 1994
30. Heeger PS, Smoyer WE, Saad T, Albert S, Kelly CJ, Neilson EG: Molecular analysis of the helper T cell response in murine interstitial nephritis. T cells recognizing an immunodominant epitope use multiple T cell receptor V beta genes with similarities across CDR3. J Clin Invest 94:2084, 1994
31. Cibotti R, Cabaniols JP, Pannetier C, Delarbre C, Vergnon I, Kanellopoulous JM, Kourilsky P: Public and private Vβ T cell receptor repertoires against hen egg while lysozyme (HEL) in nontransgenic vs HEL transgenic mice. J Exp Med 180:861, 1994
32. Castellino F, Zhong G, Germain RN: Antigen presentation by MHC class II molecules: Invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum Immunol 54:159, 1997
33. Niewiarowski S, James P, Holt JC, Harris M, Elfenbein B, Bastl C: Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood 61:1208, 1983
34. Griem P, Gleichmann E: Metal ion induced autoimmunity. Curr Opin Immunol 7:831, 1995
35. Griem P, Panthel K, Kalbacher H, Gleichmann E: Alteration of a model antigen Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol 26:279, 1996
36. Sercarz EE, Lehman PV, Ametani A, Benichon G, Miller A, Mondgil K: Dominance and crypticity of T cell antigenic determinants. Ann Rev Immunol 11:729, 1993
37. Lehman PV, Sercarz EE, Forsthuber T, Dyan CM, Gammon G: Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 14:203, 1993
38. Elson OL, Barker RN, Thompson SJ, Williams NA: Immunologically ignorant, autoreactive T cells, epitope spreading, repertoire limitation. Immunol Today 16:71, 1995
39. Vanderlugt CL, Belgolka WS, Neville KL, Katz-Levy Y, Howard LM, Eager TN, Bluestone JA, Miller SD: The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 164:63-72, 1998